Literature DB >> 20705525

A novel ytterbium-169 brachytherapy source and delivery system for use in conjunction with minimally invasive wedge resection of early-stage lung cancer.

Kara Lynne Leonard1, Thomas A DiPetrillo, John J Munro, David E Wazer.   

Abstract

PURPOSE: To describe a novel source-delivery system for intraoperative brachytherapy in patients with early-stage lung cancer that is readily adaptable to a video-assisted thoracoscopic surgery approach and can be precisely delivered to achieve optimal dose distribution. METHODS AND MATERIALS: Radioactive ytterbium-169 ((169)Yb) was sealed within a titanium tube 0.28 mm in diameter and then capped and resealed by titanium wires laser welded to the tube to serve as the legs of a tissue-fastening system. Dose simulations were performed using Monte Carlo computer code (Los Alamos National Laboratory, Los Alamos, NM) to mimic the geometric and elemental compositions of the source, fastening apparatus, and surroundings.
RESULTS: Five test source capsules were subjected to a tensile load to failure. Failure in each capsule occurred in the wire of the fastener leg; there were no weld failures. Monte Carlo simulations and subsequent dose measurement showed the perturbation by the source legs in the deployed (bent over) position to be small (4-5%) for (169)Yb and much less than that for iodine-125 (32%).
CONCLUSION: We have developed a (169)Yb brachytherapy source-delivery system that can be used in conjunction with commercially available surgical stapling instruments, facilitates the precise placement of brachytherapy sources relative to the surgical margin, assures the seeds remain fixed in their precise position for the duration of the treatment, overcomes the technical difficulties of manipulating the seeds through the narrow surgical incision associated with video-assisted thoracoscopic surgery, and reduces the radiation dose to the clinicians.
Copyright © 2011 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705525      PMCID: PMC3208831          DOI: 10.1016/j.brachy.2010.06.006

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  22 in total

1.  An analysis of MCNP cross-sections and tally methods for low-energy photon emitters.

Authors:  John J Demarco; Robert E Wallace; Kirsten Boedeker
Journal:  Phys Med Biol       Date:  2002-04-21       Impact factor: 3.609

2.  Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.

Authors:  Tim D Bohm; Paul M DeLuca; Larry A DeWerd
Journal:  Med Phys       Date:  2003-04       Impact factor: 4.071

3.  The radial dose function of low-energy brachytherapy seeds in different solid phantoms: comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements.

Authors:  B Reniers; F Verhaegen; S Vynckier
Journal:  Phys Med Biol       Date:  2004-04-21       Impact factor: 3.609

4.  Phantom size in brachytherapy source dosimetric studies.

Authors:  J Pérez-Calatayud; D Granero; F Ballester
Journal:  Med Phys       Date:  2004-07       Impact factor: 4.071

5.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.

Authors:  Mark J Rivard; Bert M Coursey; Larry A DeWerd; William F Hanson; M Saiful Huq; Geoffrey S Ibbott; Michael G Mitch; Ravinder Nath; Jeffrey F Williamson
Journal:  Med Phys       Date:  2004-03       Impact factor: 4.071

6.  Placement of 125I implants with the da Vinci robotic system after video-assisted thoracoscopic wedge resection: a feasibility study.

Authors:  Julianna Pisch; Scott J Belsley; Robert Ashton; Lin Wang; Rudolph Woode; Cliff Connery
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-01       Impact factor: 7.038

7.  The potential of ytterbium 169 in brachytherapy: a brief physical and radiobiological assessment.

Authors:  S M Loft; I P Coles; R G Dale
Journal:  Br J Radiol       Date:  1992-03       Impact factor: 3.039

Review 8.  Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature.

Authors:  Alexandra J Stewart; Subhakar Mutyala; Caroline L Holloway; Yolonda L Colson; Phillip M Devlin
Journal:  Brachytherapy       Date:  2008-12-03       Impact factor: 2.362

9.  Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence.

Authors:  W H Warren; L P Faber
Journal:  J Thorac Cardiovasc Surg       Date:  1994-04       Impact factor: 5.209

10.  The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection.

Authors:  Y Ichinose; T Yano; H Yokoyama; T Inoue; H Asoh; Y Katsuda
Journal:  J Thorac Cardiovasc Surg       Date:  1994-10       Impact factor: 5.209

View more
  2 in total

1.  Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.

Authors:  Blake Currier; John J Munro; David C Medich
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

2.  Decreased cervical cancer cell adhesion on nanotubular titanium for the treatment of cervical cancer.

Authors:  Jara Crear; Kim M Kummer; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2013-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.